Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-25-000132
Filing Date
2025-01-29
Accepted
2025-01-29 16:24:39
Documents
1
Period of Report
2025-01-27

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 4997
  Complete submission text file 0000897069-25-000132.txt   6517
Mailing Address 8850 STANFORD BOULEVARD SUITE 2500 COLUMBIA MD 21045
Business Address
Young David (Reporting) CIK: 0001378166 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 25569692

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)